Tobii AB (publ) (TBIIF)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	75	45	62	170	426	683
Market Cap Growth	97.25%	-27.41%	-63.40%	-60.10%	-37.63%	71.65%
Enterprise Value	101	69	44	153	464	716
Last Close Price	0.32	0.20	0.61	1.57	4.08	7.00
PE Ratio	35.68	-	-	-	1.22	-
PS Ratio	0.73	0.58	0.83	2.28	6.25	9.70
PB Ratio	1.11	0.74	1.11	2.35	4.57	10.09
P/TBV Ratio	-	1.42	1.45	2.78	5.29	14.68
P/FCF Ratio	2.40	99.92	7.54	13.22	154.01	31.32
P/OCF Ratio	3.30	71.37	6.58	13.02	124.20	30.15
EV/Sales Ratio	0.98	0.89	0.59	2.05	6.80	10.17
EV/EBITDA Ratio	6.27	-	-	-	-	-
EV/FCF Ratio	3.22	152.12	5.34	11.87	167.65	32.85
Debt / Equity Ratio	0.61	0.64	0.14	0.09	0.11	1.00
Debt / FCF Ratio	1.32	86.40	0.95	0.52	3.76	3.09
Asset Turnover	0.53	0.58	0.64	0.63	0.43	0.35
Inventory Turnover	2.87	2.32	2.83	3.10	2.41	1.80
Quick Ratio	0.47	0.63	0.77	1.47	2.09	1.42
Current Ratio	0.87	0.84	0.97	1.69	2.37	1.67
Return on Equity (ROE)	2.88%	-28.52%	-30.20%	-12.41%	-26.18%	-43.02%
Return on Assets (ROA)	2.27%	-4.62%	-9.22%	-6.69%	-8.25%	-8.52%
Return on Capital (ROIC)	3.95%	-7.85%	-14.92%	-9.31%	-11.61%	-12.88%
Earnings Yield	2.80%	-35.43%	-31.82%	-5.65%	81.74%	-2.39%
FCF Yield	41.62%	1.00%	13.27%	7.57%	0.65%	3.19%
Buyback Yield / Dilution	-73.24%	-88.34%	-0.27%	-5.35%	-1.29%	-0.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.